Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 802 results for "Us Injectables Llc"

Themis Medicare soars 5.7%

The company said in a notice to BSE that it will partner Nevakar LLC for developing and commercialize injected products for US. India Infoline, 2 months ago

1 images for "Us Injectables Llc"

Nasdaq, 7 months ago

EMA Begins Review of Select Injectable Allergy Medications

The Pharmacovigilance Risk Assessment Committee of the European Medicines Agency (EMA) has begun a review of select injectable allergy medications containing methylprednisolone because they may pose risks to those who are allergic to cows' milk, ...
 Dermatology Online Journal1 day ago

William J. Link, PhD, Joins Allegro Ophthalmics Board of Directors

SAN JUAN CAPISTRANO, Calif.--( BUSINESS WIRE )--Allegro Ophthalmics, LLC, a biotechnology company focused on the development of novel therapies to treat vitreoretinal diseases, today announced that William J. Link, PhD, has been elected to Allegro's ...
 Business Wire1 week ago
[x]  

Linde Targets Productivity of Mixer Chilling with Hygienic LIXSHOOTER® Bottom Injectors

BRIDGEWATER, N.J., Dec. 2, 2016 /PRNewswire/ -- To help processors of meat, poultry, and other foods raise the bar on food safety and productivity in mixer chilling operations, Linde LLC announces new LIXSHOOTER® bottom injectors, which are ...
 TickerTech.com1 day ago
[x]  
International Business Times

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016

/ Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Mylan N.V. ("Mylan" or the "Company") ( NASDAQ: MYL ) and certain of its officers, on behalf of shareholders who purchased Mylan securities ...
 Nation's Restaurant News1 day ago DEADLINE ALERT Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016  SSUChronicle.com1 day ago SHAREHOLDER ALERT - BRONSTEIN, GEWIRTZ & GROSSMAN, LLC REMINDS INVESTORS OF CLASS ACTION AGAINST MYLAN N.V. (MYL) AND LEAD PLAINTIFF DEADLINE : December 12, 2016  4 Traders4 days ago MYLAN NV : DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Mylan N.V. (MYL) and Lead Plaintiff Deadline: December 12, 2016  4 Traders1 day ago
[x]  

Crystal Research Associates, LLC Issues Executive Informational Overview on Hemispherx Biopharma, Inc.

Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO) on Hemispherx Biopharma, Inc. (NYSE MKT: HEB). The full 60-page report is available on Crystal Research Associates' website at ...
 Stockwatch2 days ago
[x]  
VideoBasedTutorials

Linde Highlights Advanced Convection Technology for Heat Treatment

BRIDGEWATER, N.J., Nov. 30, 2016 /PRNewswire/ -- Akin Malas, head of metals market applications technology for Linde LLC, Americas, detailed advancements in furnace atmosphere circulation technology in a case study presentation to a well-attended ...
 TickerTech.com3 days ago
[x]  
Freshnews.com

11/23/16 - Phase 3 Study Results Supporting U.S. FDA and European Commission Approvals of STELARA in the Treatment of Moderately to Severely Active Crohn's Disease Published in The New England Journal of Medicine

Release date- 22112016 - SPRING HOUSE, P.A- Results from three pivotal Janssen Research & Development, LLC (Janssen)-sponsored Phase 3 studies published today in The New England Journal of Medicine show that treatment with STELARA(ustekinumab) ...
 Pharmacy Choice1 week ago Phase 3 Study Results Supporting U.S. FDA and European Commission Approvals of STELARA® in the Treatment of Moderately to Severely Active Crohn's Disease Published in The New England Journal of Medici  BioSpace2 weeks ago New Phase 3 Monotherapy Study of Sirukumab Versus Humira® and Sirukumab Data in...  Freshnews.com2 weeks ago 11/17/16 - PHASE 3 STUDY RESULTS SUPPORTING U.S. FDA AND EUROPEAN COMMISSION APPROVALS OF STELARA IN THE TREATMENT OF MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE  Pharmacy Choice2 weeks ago
[x]  
International Business Times

Linde Safety Solution for Heat Treatment Furnaces Monitors Supply of Nitrogen Needed for Safety Purge

BRIDGEWATER, N.J., Nov. 15, 2016 /PRNewswire/ -- Linde LLC helps companies operating by installing a protective-atmosphere safety monitoring system in compliance with the National Fire Protection Association's "Standard for Ovens and Furnaces" (NFPA ...
 International Business Times2 weeks ago
[x]  
Freshnews.com

Johnson & Johnson Innovation And Award U.S. $1.5 Million In Grants For World Without Disease Quickfire Challenge

NEW YORK , Nov. 14, 2016 /PRNewswire/ -- Johnson & Johnson Innovation LLC and Janssen Research & Development, LLC (Janssen) today announced multiple recipients of U.S. $500,000 grants and offers of residency at Johnson & Johnson Innovation | JLABS ...
 BioSpace2 weeks ago Johnson & Johnson Innovation and Janssen Award U.S. $1.5 Million in Grants for World Without Disease QuickFire Challenge  WorldNetDaily2 weeks ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less